this post was submitted on 24 Aug 2025
110 points (87.2% liked)
Technology
74461 readers
2306 users here now
This is a most excellent place for technology news and articles.
Our Rules
- Follow the lemmy.world rules.
- Only tech related news or articles.
- Be excellent to each other!
- Mod approved content bots can post up to 10 articles per day.
- Threads asking for personal tech support may be deleted.
- Politics threads may be removed.
- No memes allowed as posts, OK to post as comments.
- Only approved bots from the list below, this includes using AI responses and summaries. To ask if your bot can be added please contact a mod.
- Check for duplicates before posting, duplicates may be removed
- Accounts 7 days and younger will have their posts automatically removed.
Approved Bots
founded 2 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
The original study: [Paper] - Plaque Begets Plaque, ApoB Does Not: Longitudinal Data From the KETO-CTA Trial - 2025
The update with new AI imaging: New KETO-CTA Data - Clarification and Update on Cleerly
These didn't really get downvoted because the trigger words were avoided, and the communities are actively pruned of disinterested people, if you are looking for downvote brigading I could dig up examples for you
where does it say that in the study you linked?
as far as i can tell it says Plaque progression occurred, just wasn’t linked to ApoB or LDL-C levels.
Right, so the paper using the cleerly model only showed one person reversing plaque, but the two new ai models which don't have a artificial floor, do show 30% plaque reversal. That's the second reference to the YouTube talk.
The interesting thing here, is this group of 100 people following a strict ketogenic diet, mostly carnivore, had imaging done at the beginning and the end of a year. So we can apply any models to it that we like, it's interesting that in 2/3 of the AI imaging models they show 30% of the people with plaque regression
The benefit of AI here is it makes it a quantitative analysis, assuming the AI model is stable. When we involve the humans to do scoring, there's always a question about consistency, and bias in the outcomes.
As far as I'm aware plaque regression is basically unheard of at all in any literature outside of case studies
are the ai models part of a peer reviewed update to the paper?
The paper hasn't been updated, the cleerly AI is part of the original paper.
The updated model data is presented in a preliminary form in the lecture, papers still pending.
What does Dave Feldman have to do with the study and how did he get these preliminary results?
he funded the study, organized it, sourced the volunteers, etc.
i see, the guy who is not a doctor but sells subscription services as “diet doctor” is continuing to fund the study until the results support his business.
DietDoctor is a group of doctors focused on metabolic health, it does not have a relationship with Feldman. https://www.dietdoctor.com/about/team-diet-doctor
David Feldman has never called himself a doctor
Yes, people with agendas fund science, the results speak for themselves, that is the purpose of science - publish reproducible results for others to replicate.